Latigo在将IPO规模扩大至3.456亿美元后,即将于纳斯达克首日上市,开盘有望走高

路透中文
Aug 07
BUZZ-Latigo在将IPO规模扩大至3.456亿美元后,即将于纳斯达克首日上市,开盘有望走高

8月7日 - ** 药物开发商Latigo BiotherapeuticsLTGO.O)完成3.456亿美元美国IPO后,纳斯达克首日上市开盘价有望高于发行价

** 该股最新显示开盘价为每股20美元,高于18美元的发行价

** 总部位于加利福尼亚州千橡市的LTGO公司通过规模扩大的首次公开募股,以每股18美元的价格售出 (link) 1920万股

** LTGO正在开发非阿片类止痛药,旨在阻断疼痛传导且无成瘾风险,该公司最初发售了 (link) 1600万股,每股定价区间为16至18美元

** 其主力候选产品LTG-001正在研发中,旨在为急性疼痛提供起效迅速且能减少阿片类药物用量的缓解方案

** 高盛杰富瑞、利林克合伙公司和古根海姆证券担任此次发行的联合簿记管理人

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10